{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:10:29Z","timestamp":1778602229892,"version":"3.51.4"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpm-2025-0291_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore serum vascular endothelial growth factor (VEGF), \u03b2-subunit human chorionic gonadotropin (\u03b2-hCG), and soluble Fms-like tyrosine kinasereceptor 1 (sFlt-1) levels in pregnant women with placenta accreta spectrum (PAS) and their prognostic implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0291_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum levels were measured in PAS patients and non-PAS controls. Depending on the depth of placental penetration into the uterine wall, PAS patients were further classified into placenta accreta, placenta increta and placenta percreta subgroups. Diagnostic efficacy of individual biomarkers and combined indices was evaluated using receiver operating characteristic curves. Correlations between biomarker levels, disease severity, and prognosis were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0291_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum levels of VEGF and \u03b2-hCG showed significant positive correlations with the extent of PAS invasion, whereas sFlt-1 levels were inversely associated with disease progression. Combined pregnancy complications, elevated serum VEGF levels and decreased serum sFlt-1 levels were risk factors for poor prognosis in patients with PAS. The AUC values of the indicators combined to predict the diagnosis and prognosis of patients with PAS were greater than serum VEGF, hCG, and sFlt-1 levels\u00a0alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpm-2025-0291_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum levels of VEGF, \u03b2-hCG, and sFlt-1 demonstrate the potential to differentiate between women with and without PAS, and further exhibit a correlation with the depth of myometrial invasion in PAS cases. The combined use of these serum markers enhances both the sensitivity and specificity of prenatal diagnosis and prognostic assessment for PAS compared to individual markers, thereby offering valuable guidance for clinical diagnosis and management of\u00a0PAS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpm-2025-0291","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T11:57:57Z","timestamp":1764676677000},"page":"493-499","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of changes in serum VEGF, \u03b2-hCG, and sFlt-1 levels in women with placenta accreta spectrum and the impact on prognosis"],"prefix":"10.1515","volume":"54","author":[{"given":"Pan","family":"Shang","sequence":"first","affiliation":[{"name":"Department of Gynaecology and Obstetrics , 372209 Jiangsu Taizhou People\u2019s Hospital , Taizhou City , Jiangsu Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DongMei","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics , 372209 Jiangsu Taizhou People\u2019s Hospital , Taizhou City , Jiangsu Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6083-711X","authenticated-orcid":false,"given":"YinLing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics , 372209 Jiangsu Taizhou People\u2019s Hospital , Taizhou City , Jiangsu Province , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026051215133578593_j_jpm-2025-0291_ref_001","doi-asserted-by":"crossref","unstructured":"Einerson, BD, Gilner, JB, Zuckerwise, LC. Placenta accreta spectrum. Obstet Gynecol 2023;142:31\u201350. https:\/\/doi.org\/10.1097\/aog.0000000000005229.","DOI":"10.1097\/AOG.0000000000005229"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_002","doi-asserted-by":"crossref","unstructured":"Adu-Bredu, TK, Collins, SL, Nieto-Calvache, AJ. Ultrasound discrimination between placenta accreta spectrum and urinary bladder varices. Aust N Z J Obstet Gynaecol 2023;63:725\u20137. https:\/\/doi.org\/10.1111\/ajo.13703.","DOI":"10.1111\/ajo.13703"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_003","doi-asserted-by":"crossref","unstructured":"Hawkins, R, Evans, M, Hammond, S, Hartopp, R, Evans, E. Placenta accreta spectrum disorders - peri-operative management: the role of the anaesthetist. Best Pract Res Clin Obstet Gynaecol 2021;72:38\u201351. https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.08.003.","DOI":"10.1016\/j.bpobgyn.2020.08.003"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_004","unstructured":"Melincovici, CS, Bo\u015fca, AB, \u015eu\u015fman, S, M\u0103rginean, M, Mihu, C, Istrate, M, et al.. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol 2018;59:455\u201367."},{"key":"2026051215133578593_j_jpm-2025-0291_ref_005","doi-asserted-by":"crossref","unstructured":"Dighe, M. Intraplacental fetal vessels: an additional sign for placenta accreta spectrum. Radiology 2021;298:413\u20134. https:\/\/doi.org\/10.1148\/radiol.2020204118.","DOI":"10.1148\/radiol.2020204118"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_006","doi-asserted-by":"crossref","unstructured":"Trottmann, F, Raio, L, Amylidi-Mohr, S, Mosimann, B, Jarquin Campos, A, Messerli, FH, et al.. Soluble fms-like tyrosine kinase 1 (sFlt-1): a novel biochemical marker for acute fatty liver of pregnancy. Acta Obstet Gynecol Scand 2021;100:1876\u201384. https:\/\/doi.org\/10.1111\/aogs.14218.","DOI":"10.1111\/aogs.14218"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_007","doi-asserted-by":"crossref","unstructured":"Uyan\u0131ko\u011flu, H, \u0130nceb\u0131y\u0131k, A, Turp, AB, \u00c7akmak, G, Sak, S, Hilali, NG. Serum angiogenic and anti-angiogenic markers in pregnant women with placenta percreta. Balkan Med J 2018;35:55\u201360. https:\/\/doi.org\/10.4274\/balkanmedj.2016.1890.","DOI":"10.4274\/balkanmedj.2016.1890"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_008","doi-asserted-by":"crossref","unstructured":"Liz\u00e1rraga-Verdugo, E, Beltr\u00e1n-Ontiveros, SA, Guti\u00e9rrez-Grijalva, EP, Montoya-Moreno, M, Guti\u00e9rrez-Arzapalo, PY, Avenda\u00f1o-F\u00e9lix, M, et al.. The underlying molecular mechanisms of the aaccreta spectrum: a narrative review. Int J Mol Sci. 2024;25:9722. https:\/\/doi.org\/10.3390\/ijms25179722.","DOI":"10.3390\/ijms25179722"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_009","doi-asserted-by":"crossref","unstructured":"Evans, J. Hyperglycosylated HhCG: a unique human implantation and invasion factor. Am J Reprod Immunol 2016;75:333\u201340. https:\/\/doi.org\/10.1111\/aji.12459.","DOI":"10.1111\/aji.12459"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_010","doi-asserted-by":"crossref","unstructured":"Makrigiannakis, A, Vrekoussis, T, Zoumakis, E, Kalantaridou, SN, Jeschke, U. The role of HCG in implantation: a mini-review of molecular and clinical evidence. Int J Mol Sci 2017;18:1305. https:\/\/doi.org\/10.3390\/ijms18061305.","DOI":"10.3390\/ijms18061305"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_011","doi-asserted-by":"crossref","unstructured":"Cai, SN, Wu, YT, Zeng, L, Ding, YQ. Value of 3D ultrasound flow imaging combined with serum AFP, \u03b2-hCG, sFlt-1 and CK in the diagnosis of placenta accreta. BMC Womens Health 2022;22:556. https:\/\/doi.org\/10.1186\/s12905-022-02107-z.","DOI":"10.1186\/s12905-022-02107-z"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_012","doi-asserted-by":"crossref","unstructured":"Bayramo\u011flu Tepe, N, Gelebek Yilmaz, F, Bozdag, Z, U\u011fur, MG. Subgroup analysis of accreta, increta and percreta cases using acoustic radiation force impulse elastography. J\u00a0Obstet Gynaecol Res 2020;46:699\u2013706. https:\/\/doi.org\/10.1111\/jog.14229.","DOI":"10.1111\/jog.14229"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_013","doi-asserted-by":"crossref","unstructured":"Yang, X, Zheng, W, Yan, J, Yang, H. Comparison between placenta accreta scoring system, ultrasound staging, and clinical classification. Medicine (Baltim) 2022;101:e31622. https:\/\/doi.org\/10.1097\/md.0000000000031622.","DOI":"10.1097\/MD.0000000000031622"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_014","doi-asserted-by":"crossref","unstructured":"Young, D, Khan, N, Hobson, SR, Sussman, D. Diagnosis of placenta accreta spectrum using ultrasound texture feature fusion and machine learning. Comput Biol Med 2024;178:108757. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108757.","DOI":"10.1016\/j.compbiomed.2024.108757"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_015","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Ayres-de-Campos, D, Langhoff-Roos, J, Fox, KA, Collins, S, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet 2019;146:20\u20134. https:\/\/doi.org\/10.1002\/ijgo.12761.","DOI":"10.1002\/ijgo.12761"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_016","doi-asserted-by":"crossref","unstructured":"Jauniaux, E, Collins, S, Burton, GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018;218:75\u201387. https:\/\/doi.org\/10.1016\/j.ajog.2017.05.067.","DOI":"10.1016\/j.ajog.2017.05.067"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_017","doi-asserted-by":"crossref","unstructured":"Afshar, Y, Kashani Ligumsky, L, Bartels, HC, Krakow, D. Biology and pathophysiology of placenta accreta spectrum disorder. Obstet Gynecol 2025;145:611\u201320 https:\/\/doi.org\/10.1097\/aog.0000000000005903.","DOI":"10.1097\/AOG.0000000000005903"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_018","doi-asserted-by":"crossref","unstructured":"Segal, TR, Amini, P, Wang, J, Peters, G, Skomorovska-Prokvolit, Y, Mainigi, MA, et al.. Superovulation with human chorionic gonadotropin (hCG) trigger and gonadotropin releasing hormone agonist (GnRHa) trigger differentially alter essential angiogenic factors in the endometrium in a mouse ART model. Biol Reprod. 2020;102:1122\u201333. https:\/\/doi.org\/10.1093\/biolre\/ioaa014.","DOI":"10.1093\/biolre\/ioaa014"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_019","doi-asserted-by":"crossref","unstructured":"Matsuzaki, S, Nagase, Y, Takiuchi, T, Kakigano, A, Mimura, K, Lee, M, et al.. Antenatal diagnosis of placenta accreta spectrum after in\u00a0vitro fertilization-embryo transfer: a systematic review and meta-analysis. Sci Rep 2021;11:9205. https:\/\/doi.org\/10.1038\/s41598-021-88551-7.","DOI":"10.1038\/s41598-021-88551-7"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_020","doi-asserted-by":"crossref","unstructured":"Svanvik, T, Jacobsson, AK, Carlsson, Y. Prenatal detection of placenta previa and placenta accreta spectrum: evaluation of the routine mid-pregnancy obstetric ultrasound screening between 2013 and 2017. Int J Gynaecol Obstet 2022;157:647\u201353. https:\/\/doi.org\/10.1002\/ijgo.13876.","DOI":"10.1002\/ijgo.13876"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_022","doi-asserted-by":"crossref","unstructured":"Schumacher, A, Zenclussen, AC. Human chorionic gonadotropin-mediated immune responses that facilitate embryo implantation and placentation. Front Immunol 2019;10:2896. https:\/\/doi.org\/10.3389\/fimmu.2019.02896.","DOI":"10.3389\/fimmu.2019.02896"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_023","doi-asserted-by":"crossref","unstructured":"B\u00fcke, B, Akkaya, H, Demir, S, Sa\u011fol, S, \u015eim\u015fek, D, Ba\u015fol, G, et al.. Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta. J\u00a0Matern Fetal Neonatal Med 2018;31:59\u201362. https:\/\/doi.org\/10.1080\/14767058.2016.1275546.","DOI":"10.1080\/14767058.2016.1275546"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_024","doi-asserted-by":"crossref","unstructured":"Berezowsky, A, Pardo, J, Ben-Zion, M, Wiznitzer, A, Aviram, A. Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study. Fetal Diagn Ther 2019;46:187\u201392. https:\/\/doi.org\/10.1159\/000492829.","DOI":"10.1159\/000492829"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_025","doi-asserted-by":"crossref","unstructured":"Chau, K, Xu, B, Hennessy, A, Makris, A. Effect of placental growth factor on trophoblast-endothelial cell interactions in\u00a0vitro. Reprod Sci 2020;27:1285\u201392. https:\/\/doi.org\/10.1007\/s43032-019-00103-7.","DOI":"10.1007\/s43032-019-00103-7"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_026","doi-asserted-by":"crossref","unstructured":"Valent, AM, Choi, H, Kolahi, KS, Thornburg, KL. Hyperglycemia and\u00a0gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing. FASEB J 2021;35:e21423. https:\/\/doi.org\/10.1096\/fj.202000326rr.","DOI":"10.1096\/fj.202000326RR"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_027","doi-asserted-by":"crossref","unstructured":"Silasi, M, You, Y, Simpson, SJ, Kaislasuo, J, Pal, L, Guller, S, et al.. Human chorionic Kaislasuo gonadotropin modulates CXCL10 expression through histone methylation in human decidua. Sci Rep 2020;10:5785. https:\/\/doi.org\/10.1038\/s41598-020-62593-9.","DOI":"10.1038\/s41598-020-62593-9"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_028","doi-asserted-by":"crossref","unstructured":"Bachmann, C, Abele, H, Hoopmann, M. Placenta previa et percreta: a potentially life-threatening condition. Diagnostics 2023;13:539. https:\/\/doi.org\/10.3390\/diagnostics13030539.","DOI":"10.3390\/diagnostics13030539"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_029","doi-asserted-by":"crossref","unstructured":"T\u00eernovanu, MC, T\u00eernovanu, VG, Toma, B, Toma, L, \u021aarc\u0103, E, St\u0103tescu, L, et al.. Unexpected dramatic evolution of placenta increta: case report and literature review. J\u00a0Personalized Med 2023;13:1563. https:\/\/doi.org\/10.3390\/jpm13111563.","DOI":"10.3390\/jpm13111563"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_030","doi-asserted-by":"crossref","unstructured":"El-Badawy, O, Abbas, AM, Radwan, E, Makboul, R, Khamis, AA, Ali, M, et al.. Cross-talk between mucosal-associated invariant T, natural killer, and natural killer T\u00a0cell populations is implicated in the pathogenesis of placenta accreta spectrum. Inflammation 2023;46:1192\u2013208. https:\/\/doi.org\/10.1007\/s10753-023-01799-1.","DOI":"10.1007\/s10753-023-01799-1"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_031","doi-asserted-by":"crossref","unstructured":"Ji, Y, Zhou, L, Wang, G, Qiao, Y, Tian, Y, Feng, Y. Role of LAMA4 gene in regulating extravillous trophoblasts in pathogenesis of preeclampsia. Med Sci Monit 2019;25:9630\u20136. https:\/\/doi.org\/10.12659\/msm.917402.","DOI":"10.12659\/MSM.917402"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_032","doi-asserted-by":"crossref","unstructured":"Maurea, S, Verde, F, Romeo, V, Stanzione, A, Mainenti, PP, Raia, G, et al.. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: a retrospective study with external validation. Eur J Radiol 2023;168:111116. https:\/\/doi.org\/10.1016\/j.ejrad.2023.111116.","DOI":"10.1016\/j.ejrad.2023.111116"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_033","doi-asserted-by":"crossref","unstructured":"Lumbanraja, S, Yaznil, MR, Siahaan, AM, Berry Eka Parda, B. Soluble FMS-like tyrosine kinase-1: role in placenta accreta spectrum disorder. F1000Res 2021;10:618. https:\/\/doi.org\/10.12688\/f1000research.54719.1.","DOI":"10.12688\/f1000research.54719.2"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_034","doi-asserted-by":"crossref","unstructured":"Zhang, F, Gu, M, Chen, P, Wan, S, Zhou, Q, Lu, Y, et al.. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1\/PLGF ratio. Placenta 2022;124:48\u201354. https:\/\/doi.org\/10.1016\/j.placenta.2022.05.009.","DOI":"10.1016\/j.placenta.2022.05.009"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_035","doi-asserted-by":"crossref","unstructured":"Schwickert, A, Chantraine, F, Ehrlich, L, Henrich, W, Muallem, MZ, Nonnenmacher, A, et al.. Maternal serum VEGF predicts abnormally invasive placenta better than NT-proBNP: a multicenter case-control study. Reprod Sci 2021;28:361\u201370. https:\/\/doi.org\/10.1007\/s43032-020-00319-y.","DOI":"10.1007\/s43032-020-00319-y"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_036","doi-asserted-by":"crossref","unstructured":"Holmes, VJ, Skinner, S, Silagy, M, Rolnik, DL, Mol, BW, Kroushev, A. Changes in practice and management of placenta accreta spectrum disorder: a 20-year retrospective cohort study. Aust N Z J Obstet Gynaecol 2023;63:786\u201391. https:\/\/doi.org\/10.1111\/ajo.13724.","DOI":"10.1111\/ajo.13724"},{"key":"2026051215133578593_j_jpm-2025-0291_ref_037","doi-asserted-by":"crossref","unstructured":"Trapiella-Alfonso, L, Alexandre, L, Fraichard, C, Pons, K, Dumas, S, Huart, L, et al.. VEGF (vascular endothelial growth factor) functionalized magnetic beads in a microfluidic device to improve the angiogenic balance in preeclampsia. Hypertension 2019;74:145\u201353. https:\/\/doi.org\/10.1161\/hypertensionaha.118.12380.","DOI":"10.1161\/HYPERTENSIONAHA.118.12380"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0291\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0291\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:25:19Z","timestamp":1778599519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpm-2025-0291\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,22]]},"published-print":{"date-parts":[[2026,3,26]]}},"alternative-id":["10.1515\/jpm-2025-0291"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2025-0291","relation":{},"ISSN":["0300-5577","1619-3997"],"issn-type":[{"value":"0300-5577","type":"print"},{"value":"1619-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}